Annette Hay

Queen's University

Research Interests

Explore related searches

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

Articles (11)

Collaborators (5)

Bingshu Chen

Queen's University

Abi Vijenthira

UNITED STATES

Joan Tranmer

Monakshi Sawhney

Associate Professor

Queen's University

Armand Keating

University of Toronto

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Annette Hay

Research Interests

Explore related searches

Contact this professor

Articles (11)

Collaborators (5)

Bingshu Chen

Abi Vijenthira

Joan Tranmer

Monakshi Sawhney

Armand Keating

Make your next move.

Annette Hay

Research Interests

Explore related searches

Contact this professor

Articles (11)

Outcomes following exposure to drug interactions with ibrutinib in patients with chronic lymphocytic leukaemia

Incremental immunogenicity of multiple doses of SARS‐CoV‐2 vaccination in patients with haematological malignancies

Determining the Associations Between Glucocorticoid Use During Hematologic Chemotherapy Treatment and New-onset Diabetes and Hyperglycemia and Mortality: A Population-based Cohort Study

COVID-19 vaccine immunogenicity and safety surrounding fourth and subsequent vaccine doses in patients with hematologic malignancies

A Phase II, Open-Label Study of an Accelerated Infusion Rate of Daratumumab in Patients With Relapsed and Refractory Multiple Myeloma

Application of Value Frameworks to the Design of Clinical Trials: The Canadian Cancer Trials Group Experience

The Past, Present, and Future of Economic Evaluations of Precision Medicine at the Committee for Economic Analyses of the Canadian Cancer Trials Group

Minimization of resource utilization data collected within cost-effectiveness analyses conducted alongside Canadian Cancer Trials Group phase III trials

Evaluating the Indirect Costs of Care Associated with Salvage Chemotherapy for Relapsed and Refractory Aggressive-Histology Lymphoma: A Subset Analysis of the Canadian Cancer Trials Group (CCTG) LY.12 Clinical Trial

Drug-induced Thrombotic Microangiopathy with Concurrent Proteasome Inhibitor Use in the Treatment of Multiple Myeloma: A Case Series and Review of the Literature

The conditional survival analysis of relapsed DLBCL after autologous transplant: a subgroup analysis of LY.12 and CORAL

Collaborators (5)

Bingshu Chen

Abi Vijenthira

Joan Tranmer

Monakshi Sawhney

Armand Keating

Make your next move.